Greg Savannah
Analyst
Guggenheim Securities
Equibles does not estimate personal net worth.
About Greg Savannah
Greg Savannah is recorded as Analyst at Guggenheim Securities. Greg Savannah has spoken on 1 earnings call across 1 company, most recently for Axsome Therapeutics, Inc. on November 2, 2026. The companies whose calls Greg Savannah spoke on are classified in the Healthcare sector.
Greg Savannah on recent calls
“Just wanted to stay on the prescription data. Could you comment just on capture rates between Symfony and IQV? I think by our look, maybe IQV capture rates stayed relatively consistent, but maybe ticked up higher.”
Affiliation history
-
Guggenheim Securities
Analyst
Transcript header (unverified)
Current